Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Mini-Review Article

Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes

Author(s): Shahzad Khan*

Volume 31, Issue 3, 2024

Published on: 19 February, 2024

Page: [178 - 191] Pages: 14

DOI: 10.2174/0109298665266730240118054023

Price: $65

Abstract

Background: Inhibitors of interleukin 6 [IL-6] have been utilized to treat severe COVID-19 disease. Their immunosuppressive or immunomodulating impact may be beneficial in COVID-19.

Objectives: To discuss the role of IL-6 inhibitors and assess various trials conducted to evaluate the efficacy of IL-6 inhibitors in COVID-19 disease.

Summary: Two of the most common causes of mortality in COVID-19-infected critically ill individuals are acute respiratory distress syndrome (ARDS) and multiorgan failure. Increased levels of inflammatory cytokines suggest that a cytokine storm, also known as cytokine release syndrome (CRS), is involved in the etiology of COVID-19. Most tissue damage, sepsis, and pulmonary and cardiovascular problems are caused mainly by the host defense system. Therefore, regulating this inflammatory cascade using immunomodulators is a prudent strategy. Although corticosteroids, as immunomodulators, are routinely used in COVID-19 management, interleukin (IL) inhibitors, especially IL-6 inhibitors, are also tested in many trials. Many studies have demonstrated that IL-6 inhibitors improve disease outcomes and decrease mortality, whereas others have shown that they are ineffective. In this paper, we briefly examined the role of IL-6 in COVID-19 pathogenesis and trials that support or refute the use of IL-6 inhibitors in treating COVID-19 disease.

Results: Though mixed results are coming from trials regarding the adjuvant use of IL-6 inhibitors and standard anti-viral therapy with dexamethasone, a consensus favors using IL-6 inhibitors in severely ill COVID-19 patients regardless of the outcome.

Keywords: IL6, COVID-19, interleukins, acute respiratory distress syndrome, IL-6 inhibitors, immunomodulators.

Graphical Abstract
[1]
Naka, T.; Nishimoto, N.; Kishimoto, T. The paradigm of IL-6: From basic science to medicine. Arthritis Res., 2002, 4(S3), S233-S242.
[2]
McElvaney, O.J.; Curley, G.F.; Rose-John, S.; McElvaney, N.G. Interleukin-6: Obstacles to targeting a complex cytokine in critical illness. Lancet Respir. Med., 2021, 9(6), 643-654.
[http://dx.doi.org/10.1016/S2213-2600(21)00103-X] [PMID: 33872590]
[3]
Noma, T.; Mizuta, T.; Rosén, A.; Hirano, T.; Kishimoto, T.; Honjo, T. Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines. Immunol. Lett., 1987, 15(3), 249-253.
[http://dx.doi.org/10.1016/0165-2478(87)90032-0] [PMID: 2889667]
[4]
Okada, M.; Kitahara, M.; Kishimoto, S.; Matsuda, T.; Hirano, T.; Kishimoto, T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J. Immunol., 1988, 141(5), 1543-1549.
[http://dx.doi.org/10.4049/jimmunol.141.5.1543] [PMID: 3261754]
[5]
Ceuppens, J.L.; Baroja, M.L.; Lorre, K.; Van Damme, J.; Billiau, A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J. Immunol., 1988, 141(11), 3868-3874.
[http://dx.doi.org/10.4049/jimmunol.141.11.3868] [PMID: 3263438]
[6]
Le, J.M.; Fredrickson, G.; Reis, L.F.; Diamantstein, T.; Hirano, T.; Kishimoto, T.; Vilcek, J. Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc. Natl. Acad. Sci., 1988, 85(22), 8643-8647.
[http://dx.doi.org/10.1073/pnas.85.22.8643] [PMID: 3263651]
[7]
Lotz, M.; Jirik, F.; Kabouridis, P.; Tsoukas, C.; Hirano, T.; Kishimoto, T.; Carson, D.A. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med., 1988, 167(3), 1253-1258.
[http://dx.doi.org/10.1084/jem.167.3.1253] [PMID: 3127525]
[8]
Garman, R.D.; Jacobs, K.A.; Clark, S.C.; Raulet, D.H. B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc. Natl. Acad. Sci., 1987, 84(21), 7629-7633.
[http://dx.doi.org/10.1073/pnas.84.21.7629] [PMID: 3499611]
[9]
Tamura, T.; Udagawa, N.; Takahashi, N.; Miyaura, C.; Tanaka, S.; Yamada, Y.; Koishihara, Y.; Ohsugi, Y.; Kumaki, K.; Taga, T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci., 1993, 90(24), 11924-11928.
[http://dx.doi.org/10.1073/pnas.90.24.11924] [PMID: 8265649]
[10]
Nicola, N.A.; Metcalf, D.; Matsumoto, M.; Johnson, G.R. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J. Biol. Chem., 1983, 258(14), 9017-9023.
[http://dx.doi.org/10.1016/S0021-9258(18)32158-6] [PMID: 6190815]
[11]
Ishibashi, T.; Kimura, H.; Uchida, T.; Kariyone, S.; Friese, P.; Burstein, S.A. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc. Natl. Acad. Sci., 1989, 86(15), 5953-5957.
[http://dx.doi.org/10.1073/pnas.86.15.5953] [PMID: 2788282]
[12]
Ishibashi, T.; Kimura, H.; Shikama, Y.; Uchida, T.; Kariyone, S.; Hirano, T.; Kishimoto, T.; Takatsuki, F.; Akiyama, Y. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood, 1989, 74(4), 1241-1244.
[http://dx.doi.org/10.1182/blood.V74.4.1241.1241] [PMID: 2788464]
[13]
Koike, K.; Nakahata, T.; Kubo, T.; Kikuchi, T.; Takagi, M.; Ishiguro, A.; Tsuji, K.; Naganuma, K.; Okano, A.; Akiyama, Y. Interleukin-6 enhances murine megakaryocytopoiesis in serum-free culture. Blood, 1990, 75(12), 2286-2291.
[http://dx.doi.org/10.1182/blood.V75.12.2286.2286] [PMID: 2350576]
[14]
Ulich, T.R.; Del Castillo, J.; Guo, K.Z. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood, 1989, 73(1), 108-110.
[http://dx.doi.org/10.1182/blood.V73.1.108.108] [PMID: 2783370]
[15]
Ikebuchi, K.; Wong, G.G.; Clark, S.C.; Ihle, J.N.; Hirai, Y.; Ogawa, M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc. Natl. Acad. Sci., 1987, 84(24), 9035-9039.
[http://dx.doi.org/10.1073/pnas.84.24.9035] [PMID: 3501121]
[16]
Koike, K.; Nakahata, T.; Takagi, M.; Kobayashi, T.; Ishiguro, A.; Tsuji, K.; Naganuma, K.; Okano, A.; Akiyama, Y.; Akabane, T. Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture. J. Exp. Med., 1988, 168(3), 879-890.
[http://dx.doi.org/10.1084/jem.168.3.879] [PMID: 3049908]
[17]
Leary, A.G.; Ikebuchi, K.; Hirai, Y.; Wong, G.G.; Yang, Y.C.; Clark, S.C.; Ogawa, M. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: Comparison with interleukin-1 alpha. Blood, 1988, 71(6), 1759-1763.
[http://dx.doi.org/10.1182/blood.V71.6.1759.1759] [PMID: 3259443]
[18]
Ogawa, M. Differentiation and proliferation of hematopoietic stem cells. Blood, 1993, 81(11), 2844-2853.
[http://dx.doi.org/10.1182/blood.V81.11.2844.2844] [PMID: 8499622]
[19]
Stanley, E.R.; Bartocci, A.; Patinkin, D.; Rosendaal, M.; Bradley, T.R. Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1. Cell, 1986, 45(5), 667-674.
[http://dx.doi.org/10.1016/0092-8674(86)90781-6] [PMID: 3085956]
[20]
Gauldie, J.; Richards, C.; Harnish, D.; Lansdorp, P.; Baumann, H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci., 1987, 84(20), 7251-7255.
[http://dx.doi.org/10.1073/pnas.84.20.7251] [PMID: 2444978]
[21]
Castell, J.V.; Gómez-Lechón, M.J.; David, M.; Hirano, T.; Kishimoto, T.; Heinrich, P.C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett., 1988, 232(2), 347-350.
[http://dx.doi.org/10.1016/0014-5793(88)80766-X] [PMID: 2454206]
[22]
Andus, T.; Geiger, T.; Hirano, T.; Northoff, H.; Ganter, U.; Bauer, J.; Kishimoto, T.; Heinrich, P.C. Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-β2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett., 1987, 221(1), 18-22.
[http://dx.doi.org/10.1016/0014-5793(87)80344-7] [PMID: 3305075]
[23]
Selvaraj, V.; Khan, M.S.; Bavishi, C.; Dapaah-Afriyie, K.; Finn, A.; Lal, A.; Mylonakis, E. Tocilizumab in hospitalized patients with COVID-19: A meta analysis of randomized controlled trials. Lung, 2021, 199(3), 239-248.
[http://dx.doi.org/10.1007/s00408-021-00451-9] [PMID: 34050796]
[24]
Chen, X. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin. Infect. Dis., 2020.
[25]
Cronstein, B.N. Interleukin-6-a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull. NYU Hosp. Jt. Dis., 2007, 65(1), S11-S15.
[PMID: 17708739]
[26]
Van Snick, J. Interleukin-6: An overview. Annu. Rev. Immunol., 1990, 8(1), 253-278.
[http://dx.doi.org/10.1146/annurev.iy.08.040190.001345] [PMID: 2188664]
[27]
Song, M.; Kellum, J.A. Interleukin-6. Crit. Care Med., 2005, 33(12), S463-S465.
[http://dx.doi.org/10.1097/01.CCM.0000186784.62662.A1] [PMID: 16340422]
[28]
Chi, L.; Li, Y.; Stehno-Bittel, L.; Gao, J.; Morrison, D.C.; Stechschulte, D.J.; Dileepan, K.N. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J. Interferon Cytokine Res., 2001, 21(4), 231-240.
[http://dx.doi.org/10.1089/107999001750169871] [PMID: 11359654]
[29]
Kappelmann, N.; Dantzer, R.; Khandaker, G.M. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology, 2021, 131, 105295.
[http://dx.doi.org/10.1016/j.psyneuen.2021.105295] [PMID: 34119855]
[30]
Shuwa, H.A.; Shaw, T.N.; Knight, S.B.; Wemyss, K.; McClure, F.A.; Pearmain, L.; Prise, I.; Jagger, C.; Morgan, D.J.; Khan, S.; Brand, O.; Mann, E.R.; Ustianowski, A.; Bakerly, N.D.; Dark, P.; Brightling, C.E.; Brij, S.; Felton, T.; Simpson, A.; Grainger, J.R.; Hussell, T.; Konkel, J.E.; Menon, M.; Ahmed, R.; Avery, M.; Birchall, K.; Charsley, E.; Chenery, A.; Chew, C.; Clark, R.; Connolly, E.; Connolly, K.; Dawson, S.; Durrans, L.; Durrington, H.; Egan, J.; Filbey, K.; Fox, C.; Francis, H.; Franklin, M.; Glasgow, S.; Godfrey, N.; Gray, K.J.; Grundy, S.; Guerin, J.; Hackney, P.; Hayes, C.; Hardy, E.; Harris, J.; John, A.; Jolly, B.; Kästele, V.; Kerry, G.; Lui, S.; Lin, L.; Mathioudakis, A.G.; Mitchell, J.; Moizer, C.; Moore, K.; Moss, S.; Baker, S.M.; Oliver, R.; Padden, G.; Parkinson, C.; Phuycharoen, M.; Saha, A.; Salcman, B.; Scott, N.A.; Sharma, S.; Shaw, J.; Shaw, J.; Shepley, E.; Smith, L.; Stephan, S.; Stephens, R.; Tavernier, G.; Tudge, R.; Wareing, L.; Warren, R.; Williams, T.; Willmore, L.; Younas, M. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med., 2021, 2(6), 720-735.e4.
[http://dx.doi.org/10.1016/j.medj.2021.03.013] [PMID: 33821250]
[31]
Johnson, D.E.; O’Keefe, R.A.; Grandis, J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol., 2018, 15(4), 234-248.
[http://dx.doi.org/10.1038/nrclinonc.2018.8] [PMID: 29405201]
[32]
Kang, S.; Tanaka, T.; Narazaki, M.; Kishimoto, T. Targeting interleukin-6 signaling in clinic. Immunity, 2019, 50(4), 1007-1023.
[http://dx.doi.org/10.1016/j.immuni.2019.03.026] [PMID: 30995492]
[33]
Rose-John, S.; Scheller, J.; Elson, G.; Jones, S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J. Leukoc. Biol., 2006, 80(2), 227-236.
[http://dx.doi.org/10.1189/jlb.1105674] [PMID: 16707558]
[34]
Rose-John, S. Interleukin-6 biology is coordinated by membrane bound and soluble receptors. Acta Biochim. Pol., 2003, 50(3), 603-611.
[http://dx.doi.org/10.18388/abp.2003_3654] [PMID: 14515143]
[35]
Heink, S.; Yogev, N.; Garbers, C.; Herwerth, M.; Aly, L.; Gasperi, C.; Husterer, V.; Croxford, A.L.; Möller-Hackbarth, K.; Bartsch, H.S.; Sotlar, K.; Krebs, S.; Regen, T.; Blum, H.; Hemmer, B.; Misgeld, T.; Wunderlich, T.F.; Hidalgo, J.; Oukka, M.; Rose-John, S.; Schmidt-Supprian, M.; Waisman, A.; Korn, T. Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells. Nat. Immunol., 2017, 18(1), 74-85.
[http://dx.doi.org/10.1038/ni.3632] [PMID: 27893700]
[36]
Tanaka, T.; Narazaki, M.; Kishimoto, T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy, 2016, 8(8), 959-970.
[http://dx.doi.org/10.2217/imt-2016-0020] [PMID: 27381687]
[37]
Pathan, N.; Hemingway, C.A.; Alizadeh, A.A.; Stephens, A.C.; Boldrick, J.C.; Oragui, E.E.; McCabe, C.; Welch, S.B.; Whitney, A.; O’Gara, P.; Nadel, S.; Relman, D.A.; Harding, S.E.; Levin, M. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet, 2004, 363(9404), 203-209.
[http://dx.doi.org/10.1016/S0140-6736(03)15326-3] [PMID: 14738793]
[38]
Kishimoto, T. The biology of interleukin-6. Blood, 1989, 74(1), 1-10.
[http://dx.doi.org/10.1182/blood.V74.1.1.1] [PMID: 2473791]
[39]
Akira, S.; Taga, T.; Kishimoto, T. Interleukin-6 in biology and medicine. Adv. Immunol., 1993, 54, 1-78.
[http://dx.doi.org/10.1016/S0065-2776(08)60532-5] [PMID: 8379461]
[40]
Hirano, T.; Kishimoto, T. Interleukin-6. In: Peptide Growth Factors and Their Receptors I; Springer, 1991; pp. 633-665.
[41]
Scheller, J. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta (BBA)-. Molecular Cell Research, 2011, 1813(5), 878-888.
[PMID: 21296109]
[42]
Hirano, T.; Akira, S.; Taga, T.; Kishimoto, T. Biological and clinical aspects of interleukin 6. Immunol. Today, 1990, 11(12), 443-449.
[http://dx.doi.org/10.1016/0167-5699(90)90173-7] [PMID: 2127356]
[43]
Partsch, G.; Steiner, G.; Leeb, B.F.; Dunky, A.; Bröll, H.; Smolen, J.S. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J. Rheumatol., 1997, 24(3), 518-523.
[PMID: 9058659]
[44]
Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 1999, 340(6), 448-454.
[http://dx.doi.org/10.1056/NEJM199902113400607] [PMID: 9971870]
[45]
Smolen, J.S.; Schoels, M.M.; Nishimoto, N.; Breedveld, F.C.; Burmester, G.R.; Dougados, M.; Emery, P.; Ferraccioli, G.; Gabay, C.; Gibofsky, A.; Gomez-Reino, J.J.; Jones, G.; Kvien, T.K.; Murakami, M.; Betteridge, N.; Bingham, C.O., III; Bykerk, V.; Choy, E.H.; Combe, B.; Cutolo, M.; Graninger, W.; Lanas, A.; Martin-Mola, E.; Montecucco, C.; Ostergaard, M.; Pavelka, K.; Rubbert-Roth, A.; Sattar, N.; Scholte-Voshaar, M.; Tanaka, Y.; Trauner, M.; Valentini, G.; Winthrop, K.L.; de Wit, M.; van der Heijde, D. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Ann. Rheum. Dis., 2013, 72(4), 482-492.
[http://dx.doi.org/10.1136/annrheumdis-2012-202469] [PMID: 23172750]
[46]
O’Shea, J.J.; Paul, W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science, 2010, 327(5969), 1098-1102.
[http://dx.doi.org/10.1126/science.1178334] [PMID: 20185720]
[47]
Kishimoto, T. IL-6: From its discovery to clinical applications. Int. Immunol., 2010, 22(5), 347-352.
[http://dx.doi.org/10.1093/intimm/dxq030] [PMID: 20410258]
[48]
Patterson, B.K.; Guevara-Coto, J.; Yogendra, R.; Francisco, E.B.; Long, E.; Pise, A.; Rodrigues, H.; Parikh, P.; Mora, J.; Mora-Rodríguez, R.A. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front. Immunol., 2021, 12, 700782.
[http://dx.doi.org/10.3389/fimmu.2021.700782] [PMID: 34262570]
[49]
Taha, S.I.; Samaan, S.F.; Ibrahim, R.A.; El-Sehsah, E.M.; Youssef, M.K. Post-COVID-19 arthritis: Is it hyperinflammation or autoimmunity? Eur. Cytokine Netw., 2021, 32(4), 83-88.
[http://dx.doi.org/10.1684/ecn.2021.0471] [PMID: 35118946]
[50]
Barros, C.M.S.S.; Freire, R.S.; Frota, E.; Santos, A.G.R.; Farias, M.E.L.; Rodrigues, M.G.A.; Silva, B.M.; Jeronimo, C.M.P.; Netto, R.L.A.; Borba, M.G.S.; Baía-da-Silva, D.; Brito-Sousa, J.D.; Xavier, M.S.; Araújo-Alexandre, M.A.; Sampaio, V.S.; Melo, G.C.; Arêas, G.T.; Hajjar, L.A.; Monteiro, W.M.; Naveca, F.G.; Costa, F.T.M.; Val, F.F.A.; Lacerda, M.V.G. Short-course of methylprednisolone improves respiratory functional parameters after 120 days in hospitalized COVID-19 patients (Metcovid Trial): A randomized clinical trial. Front. Med., 2021, 8, 758405.
[http://dx.doi.org/10.3389/fmed.2021.758405] [PMID: 34917633]
[51]
Queiroz, M.A.F.; Neves, P.F.M.; Lima, S.S.; Lopes, J.C.; Torres, M.K.S.; Vallinoto, I.M.V.C.; Bichara, C.D.A.; Santos, E.F.; de Brito, M.T.F.M.; da Silva, A.L.S.; Leite, M.M.; da Costa, F.P.; Viana, M.N.S.A.; Rodrigues, F.B.B.; de Sarges, K.M.L.; Cantanhede, M.H.D.; da Silva, R.; Bichara, C.N.C.; Berg, A.V.S.; Veríssimo, A.O.L.; Carvalho, M.S.; Henriques, D.F.; Santos, C.P.; Nunes, J.A.L.; Costa, I.B.; Viana, G.M.R.; Carneiro, F.R.O.; Palacios, V.R.C.M.; Quaresma, J.A.S.; Brasil-Costa, I.; Santos, E.J.M.; Falcão, L.F.M.; Vallinoto, A.C.R. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front. Cell. Infect. Microbiol., 2022, 12, 922422.
[http://dx.doi.org/10.3389/fcimb.2022.922422] [PMID: 35846757]
[52]
Bergamaschi, L.; Mescia, F.; Turner, L.; Hanson, A.L.; Kotagiri, P.; Dunmore, B.J.; Ruffieux, H.; De Sa, A.; Huhn, O.; Morgan, M.D.; Gerber, P.P.; Wills, M.R.; Baker, S.; Calero-Nieto, F.J.; Doffinger, R.; Dougan, G.; Elmer, A.; Goodfellow, I.G.; Gupta, R.K.; Hosmillo, M.; Hunter, K.; Kingston, N.; Lehner, P.J.; Matheson, N.J.; Nicholson, J.K.; Petrunkina, A.M.; Richardson, S.; Saunders, C.; Thaventhiran, J.E.D.; Toonen, E.J.M.; Weekes, M.P.; Göttgens, B.; Toshner, M.; Hess, C.; Bradley, J.R.; Lyons, P.A.; Smith, K.G.C. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity, 2021, 54(6), 1257-1275.e8.
[http://dx.doi.org/10.1016/j.immuni.2021.05.010] [PMID: 34051148]
[53]
Ganesh, R.; Grach, S.L.; Ghosh, A.K.; Bierle, D.M.; Salonen, B.R.; Collins, N.M.; Joshi, A.Y.; Boeder, N.D., Jr; Anstine, C.V.; Mueller, M.R.; Wight, E.C.; Croghan, I.T.; Badley, A.D.; Carter, R.E.; Hurt, R.T. The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin. Proc., 2022, 97(3), 454-464.
[http://dx.doi.org/10.1016/j.mayocp.2021.11.033] [PMID: 35135695]
[54]
Wechsler, J.B.; Butuci, M.; Wong, A.; Kamboj, A.P.; Youngblood, B.A. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy, 2022, 77(4), 1288-1291.
[http://dx.doi.org/10.1111/all.15188] [PMID: 34820848]
[55]
Wu, J.; Shen, J.; Han, Y.; Qiao, Q.; Dai, W.; He, B.; Pang, R.; Zhao, J.; Luo, T.; Guo, Y.; Yang, Y.; Wu, Q.; Jiang, W.; Zhang, J.; Zhang, M.; Li, N.; Li, W.; Xia, X. Upregulated IL-6 indicates a poor COVID-19 prognosis: A call for tocilizumab and convalescent plasma treatment. Front. Immunol., 2021, 12, 598799.
[http://dx.doi.org/10.3389/fimmu.2021.598799] [PMID: 33746945]
[56]
Zeng, F.; Huang, Y.; Guo, Y.; Yin, M.; Chen, X.; Xiao, L.; Deng, G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int. J. Infect. Dis., 2020, 96, 467-474.
[http://dx.doi.org/10.1016/j.ijid.2020.05.055] [PMID: 32425643]
[57]
Zhou, P. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579(7798), 270-273.
[58]
Turner, A.J.; Hiscox, J.A.; Hooper, N.M. ACE2: From vasopeptidase to SARS virus receptor. Trends Pharmacol. Sci., 2004, 25(6), 291-294.
[http://dx.doi.org/10.1016/j.tips.2004.04.001] [PMID: 15165741]
[59]
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 2020, 395(10223), 507-513.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[60]
Liu, B.; Li, M.; Zhou, Z.; Guan, X.; Xiang, Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun., 2020, 111, 102452.
[http://dx.doi.org/10.1016/j.jaut.2020.102452] [PMID: 32291137]
[61]
Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; Cheng, Z.; Yu, T.; Xia, J.; Wei, Y.; Wu, W.; Xie, X.; Yin, W.; Li, H.; Liu, M.; Xiao, Y.; Gao, H.; Guo, L.; Xie, J.; Wang, G.; Jiang, R.; Gao, Z.; Jin, Q.; Wang, J.; Cao, B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223), 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[62]
Fang, Y.; Zhang, H.; Xu, Y.; Xie, J.; Pang, P.; Ji, W. CT manifestations of two cases of 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 2020, 295(1), 208-209.
[http://dx.doi.org/10.1148/radiol.2020200280] [PMID: 32031481]
[63]
Neelapu, S.S.; Tummala, S.; Kebriaei, P.; Wierda, W.; Gutierrez, C.; Locke, F.L.; Komanduri, K.V.; Lin, Y.; Jain, N.; Daver, N.; Westin, J.; Gulbis, A.M.; Loghin, M.E.; de Groot, J.F.; Adkins, S.; Davis, S.E.; Rezvani, K.; Hwu, P.; Shpall, E.J. Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat. Rev. Clin. Oncol., 2018, 15(1), 47-62.
[http://dx.doi.org/10.1038/nrclinonc.2017.148] [PMID: 28925994]
[64]
Norelli, M.; Camisa, B.; Barbiera, G.; Falcone, L.; Purevdorj, A.; Genua, M.; Sanvito, F.; Ponzoni, M.; Doglioni, C.; Cristofori, P.; Traversari, C.; Bordignon, C.; Ciceri, F.; Ostuni, R.; Bonini, C.; Casucci, M.; Bondanza, A. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med., 2018, 24(6), 739-748.
[http://dx.doi.org/10.1038/s41591-018-0036-4] [PMID: 29808007]
[65]
Zhang, Y.; Li, J.; Zhan, Y.; Wu, L.; Yu, X.; Zhang, W.; Ye, L.; Xu, S.; Sun, R.; Wang, Y.; Lou, J. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect. Immun., 2004, 72(8), 4410-4415.
[http://dx.doi.org/10.1128/IAI.72.8.4410-4415.2004] [PMID: 15271897]
[66]
Gao, Y.; Li, T.; Han, M.; Li, X.; Wu, D.; Xu, Y.; Zhu, Y.; Liu, Y.; Wang, X.; Wang, L. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J. Med. Virol., 2020, 92(7), 791-796.
[http://dx.doi.org/10.1002/jmv.25770] [PMID: 32181911]
[67]
Wang, H. Multiple enzyme release, inflammation storm and hypercoagulability are prominent indicators for disease progression in COVID-19: A multi-centered, correlation study with CT imaging score. The Lancet, 2020.
[http://dx.doi.org/10.2139/ssrn.3544837]
[68]
Said, E.A.; Al-Reesi, I.; Al-Shizawi, N.; Jaju, S.; Al-Balushi, M.S.; Koh, C.Y.; Al-Jabri, A.A.; Jeyaseelan, L. Defining IL-6 levels in healthy individuals: A meta-analysis. J. Med. Virol., 2021, 93(6), 3915-3924.
[http://dx.doi.org/10.1002/jmv.26654] [PMID: 33155686]
[69]
Lai, Y.J.; Liu, S.H.; Manachevakul, S.; Lee, T.A.; Kuo, C.T.; Bello, D. Biomarkers in long COVID-19: A systematic review. Front. Med., 2023, 10, 1085988.
[http://dx.doi.org/10.3389/fmed.2023.1085988] [PMID: 36744129]
[70]
Raghavan, K. Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1, 3-1, 6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study. IBRO Neurosci. Rep., 2023, 15, 90-99.
[71]
Yin, J-X. Increased interleukin-6 is associated with long COVID-19: A systematic review and meta-analysis. Infect. Dis. Poverty, 2023, 12(1), 1-14.
[http://dx.doi.org/10.1186/s40249-022-01049-w] [PMID: 36642738]
[72]
Jarius, S.; Pache, F.; Körtvelyessy, P.; Jelčić, I.; Stettner, M.; Franciotta, D.; Keller, E.; Neumann, B.; Ringelstein, M.; Senel, M.; Regeniter, A.; Kalantzis, R.; Willms, J.F.; Berthele, A.; Busch, M.; Capobianco, M.; Eisele, A.; Reichen, I.; Dersch, R.; Rauer, S.; Sandner, K.; Ayzenberg, I.; Gross, C.C.; Hegen, H.; Khalil, M.; Kleiter, I.; Lenhard, T.; Haas, J.; Aktas, O.; Angstwurm, K.; Kleinschnitz, C.; Lewerenz, J.; Tumani, H.; Paul, F.; Stangel, M.; Ruprecht, K.; Wildemann, B. Cerebrospinal fluid findings in COVID-19: A multicenter study of 150 lumbar punctures in 127 patients. J. Neuroinflammation, 2022, 19(1), 19.
[http://dx.doi.org/10.1186/s12974-021-02339-0] [PMID: 35057809]
[73]
Low, R.N.; Low, R.J.; Akrami, A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med., 2023, 10, 1011936.
[http://dx.doi.org/10.3389/fmed.2023.1011936] [PMID: 37064029]
[74]
Bagri, N.K.; Chew, C.; Ramanan, A. Scope of JAK inhibitors in children: Recent evidence and way forward. Paediatr. Drugs, 2023, 25(6), 635-647.
[75]
Shah, R.J.; Banerjee, S.; Raychaudhuri, S.; Raychaudhuri, S.P. JAK-STAT inhibitors in Immune mediated diseases: An Overview. Indian J. Dermatol. Venereol. Leprol., 2023, 89(5), 691-699.
[http://dx.doi.org/10.25259/IJDVL_1152_2022] [PMID: 37609730]
[76]
Banday, A.Z.; Jindal, A.K.; Singh, S. Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: A consensus statement’. Ann. Rheum. Dis., 2023, 82(5), e104-e104.
[http://dx.doi.org/10.1136/annrheumdis-2021-219890] [PMID: 33674263]
[77]
Aletaha, D.; Kerschbaumer, A.; Kastrati, K.; Dejaco, C.; Dougados, M.; McInnes, I.B.; Sattar, N.; Stamm, T.A.; Takeuchi, T.; Trauner, M.; van der Heijde, D.; Voshaar, M.; Winthrop, K.L.; Ravelli, A.; Betteridge, N.; Burmester, G.R.R.; Bijlsma, J.W.J.; Bykerk, V.; Caporali, R.; Choy, E.H.; Codreanu, C.; Combe, B.; Crow, M.K.; de Wit, M.; Emery, P.; Fleischmann, R.M.; Gabay, C.; Hetland, M.L.; Hyrich, K.L.; Iagnocco, A.; Isaacs, J.D.; Kremer, J.M.; Mariette, X.; Merkel, P.A.; Mysler, E.F.; Nash, P.; Nurmohamed, M.T.; Pavelka, K.; Poor, G.; Rubbert-Roth, A.; Schulze-Koops, H.; Strangfeld, A.; Tanaka, Y.; Smolen, J.S. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: An update. Ann. Rheum. Dis., 2023, 82(6), 773-787.
[http://dx.doi.org/10.1136/ard-2022-222784] [PMID: 35953263]
[78]
Horby, P. Recovery collaborative group. Dexamethasone in hospitalized patients with Covid-19-preliminary report. N. Engl. J. Med., 2020, 384, 10.1056.
[79]
Hasanin, A.; Mostafa, M. Tocilizumab in patients with COVID-19: Which patient, time, and dose? J. Anesth., 2021, 35(6), 896-902.
[http://dx.doi.org/10.1007/s00540-021-02974-0] [PMID: 34264384]
[80]
Marinaccio, L.; Stefanucci, A.; Scioli, G.; Valle, A.D.; Zengin, G.; Cichelli, A.; Mollica, A. Peptide human neutrophil elastase inhibitors from natural sources: An overview. Int. J. Mol. Sci., 2022, 23(6), 2924.
[http://dx.doi.org/10.3390/ijms23062924] [PMID: 35328340]
[81]
Ramiro, S.; Mostard, R.L.M.; Magro-Checa, C.; van Dongen, C.M.P.; Dormans, T.; Buijs, J.; Gronenschild, M.; De Kruif, M.D.; Van Haren, E.H.J.; Van Kraaij, T.; Leers, M.P.G.; Peeters, R.; Wong, D.R.; Landewé, R.B.M. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study. Ann. Rheum. Dis., 2020, 79(9), 1143-1151.
[http://dx.doi.org/10.1136/annrheumdis-2020-218479] [PMID: 32719045]
[82]
Chen, C. Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Chin. J. Burns., 2020, 36, E005-E005.
[83]
Malgie, J.; Schoones, J.W.; Zeegers, M.P.; Pijls, B.G. Decreased mortality and increased side effects in COVID-19 patients treated with IL-6 receptor antagonists: Systematic review and meta-analysis. Sci. Rep., 2021, 11(1), 21522.
[http://dx.doi.org/10.1038/s41598-021-00726-4] [PMID: 34728658]
[84]
Gordon, A.C. Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N. Engl. J. Med., 2021.
[85]
RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet, 2021, 397(10285), 1637-1645.
[http://dx.doi.org/10.1016/S0140-6736(21)00676-0] [PMID: 33933206]
[86]
Peiris, J.S.M.; Chu, C.M.; Cheng, V.C.C.; Chan, K.S.; Hung, I.F.N.; Poon, L.L.M.; Law, K.I.; Tang, B.S.F.; Hon, T.Y.W.; Chan, C.S.; Chan, K.H.; Ng, J.S.C.; Zheng, B.J.; Ng, W.L.; Lai, R.W.M.; Guan, Y.; Yuen, K.Y. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet, 2003, 361(9371), 1767-1772.
[http://dx.doi.org/10.1016/S0140-6736(03)13412-5] [PMID: 12781535]
[87]
Hunter, C.A.; Jones, S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol., 2015, 16(5), 448-457.
[http://dx.doi.org/10.1038/ni.3153] [PMID: 25898198]
[88]
Van Roy, M.; Ververken, C.; Beirnaert, E.; Hoefman, S.; Kolkman, J.; Vierboom, M.; Breedveld, E.; Hart, B.; Poelmans, S.; Bontinck, L.; Hemeryck, A.; Jacobs, S.; Baumeister, J.; Ulrichts, H. The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res. Ther., 2015, 17(1), 135.
[http://dx.doi.org/10.1186/s13075-015-0651-0] [PMID: 25994180]
[89]
Lacroix, M.; Rousseau, F.; Guilhot, F.; Malinge, P.; Magistrelli, G.; Herren, S.; Jones, S.A.; Jones, G.W.; Scheller, J.; Lissilaa, R.; Kosco-Vilbois, M.; Johnson, Z.; Buatois, V.; Ferlin, W. Novel insights into interleukin 6 (IL-6) cis- and trans-signaling pathways by differentially manipulating the assembly of the IL-6 signaling complex. J. Biol. Chem., 2015, 290(45), 26943-26953.
[http://dx.doi.org/10.1074/jbc.M115.682138] [PMID: 26363066]
[90]
Paonessa, G.; Graziani, R.; De Serio, A.; Savino, R.; Ciapponi, L.; Lahm, A.; Salvati, A.L.; Toniatti, C.; Ciliberto, G. Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J., 1995, 14(9), 1942-1951.
[http://dx.doi.org/10.1002/j.1460-2075.1995.tb07186.x] [PMID: 7744001]
[91]
Le, R.Q.; Li, L.; Yuan, W.; Shord, S.S.; Nie, L.; Habtemariam, B.A.; Przepiorka, D.; Farrell, A.T.; Pazdur, R. FDA approval summary: Tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome. Oncologist, 2018, 23(8), 943-947.
[http://dx.doi.org/10.1634/theoncologist.2018-0028] [PMID: 29622697]
[92]
Ghosn, L. Interleukin-6 blocking agents for treating COVID-19: A living systematic review. Cochrane Database Syst. Rev., 2021, 3(3), CD013881.
[93]
Stone, J.H.; Frigault, M.J.; Serling-Boyd, N.J.; Fernandes, A.D.; Harvey, L.; Foulkes, A.S.; Horick, N.K.; Healy, B.C.; Shah, R.; Bensaci, A.M.; Woolley, A.E.; Nikiforow, S.; Lin, N.; Sagar, M.; Schrager, H.; Huckins, D.S.; Axelrod, M.; Pincus, M.D.; Fleisher, J.; Sacks, C.A.; Dougan, M.; North, C.M.; Halvorsen, Y.D.; Thurber, T.K.; Dagher, Z.; Scherer, A.; Wallwork, R.S.; Kim, A.Y.; Schoenfeld, S.; Sen, P.; Neilan, T.G.; Perugino, C.A.; Unizony, S.H.; Collier, D.S.; Matza, M.A.; Yinh, J.M.; Bowman, K.A.; Meyerowitz, E.; Zafar, A.; Drobni, Z.D.; Bolster, M.B.; Kohler, M.; D’Silva, K.M.; Dau, J.; Lockwood, M.M.; Cubbison, C.; Weber, B.N.; Mansour, M.K. Efficacy of tocilizumab in patients hospitalized with Covid-19. N. Engl. J. Med., 2020, 383(24), 2333-2344.
[http://dx.doi.org/10.1056/NEJMoa2028836] [PMID: 33085857]
[94]
Salvarani, C.; Dolci, G.; Massari, M.; Merlo, D.F.; Cavuto, S.; Savoldi, L.; Bruzzi, P.; Boni, F.; Braglia, L.; Turrà, C.; Ballerini, P.F.; Sciascia, R.; Zammarchi, L.; Para, O.; Scotton, P.G.; Inojosa, W.O.; Ravagnani, V.; Salerno, N.D.; Sainaghi, P.P.; Brignone, A.; Codeluppi, M.; Teopompi, E.; Milesi, M.; Bertomoro, P.; Claudio, N.; Salio, M.; Falcone, M.; Cenderello, G.; Donghi, L.; Del Bono, V.; Colombelli, P.L.; Angheben, A.; Passaro, A.; Secondo, G.; Pascale, R.; Piazza, I.; Facciolongo, N.; Costantini, M. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: A randomized clinical trial. JAMA Intern. Med., 2021, 181(1), 24-31.
[http://dx.doi.org/10.1001/jamainternmed.2020.6615] [PMID: 33080005]
[95]
Florescu, S.; Stanciu, D.; Zaharia, M.; Kosa, A.; Codreanu, D.; Kidwai, A.; Masood, S.; Kaye, C.; Coutts, A.; MacKay, L.; Summers, C.; Polgarova, P.; Farahi, N.; Fox, E.; McWilliam, S.; Hawcutt, D.; Rad, L.; O’Malley, L.; Whitbread, J.; Jones, D.; Dore, R.; Saunderson, P.; Kelsall, O.; Cowley, N.; Wild, L.; Thrush, J.; Wood, H.; Austin, K.; Bélteczki, J.; Magyar, I.; Fazekas, Á.; Kovács, S.; Szőke, V.; Donnelly, A.; Kelly, M.; Smyth, N.; O’Kane, S.; McClintock, D.; Warnock, M.; Campbell, R.; McCallion, E.; Azaiz, A.; Charron, C.; Godement, M.; Geri, G.; Vieillard-Baron, A.; Johnson, P.; McKenna, S.; Hanley, J.; Currie, A.; Allen, B.; McGoldrick, C.; McMaster, M.; Mani, A.; Mathew, M.; Kandeepan, R.; Vignesh, C.; Tv, B.; Ramakrishnan, N.; James, A.; Elvira, E.; Jayakumar, D.; Pratheema, R.; Babu, S.; Ebenezer, R.; Krishnaoorthy, S.; Ranganathan, L.; Ganesan, M.; Shree, M.; Guilder, E.; Butler, M.; Cowdrey, K-A.; Robertson, M.; Ali, F.; McMahon, E.; Duffy, E.; Chen, Y.; Simmonds, C.; McConnochie, R.; O’Connor, C.; El-Khawas, K.; Richardson, A.; Hill, D.; Commons, R.; Abdelkharim, H.; Saxena, M.; Muteithia, M.; Dobell-Brown, K.; Jha, R.; Kalogirou, M.; Ellis, C.; Krishnamurthy, V.; O’Connor, A.; Thurairatnam, S.; Mukherjee, D.; Kaliappan, A.; Vertue, M.; Nicholson, A.; Riches, J.; Maloney, G.; Kittridge, L.; Solesbury, A.; Ramos, A.; Collins, D.; Brickell, K.; Reid, L.; Smyth, M.; Breen, P.; Spain, S.; Curley, G.; McEvoy, N.; Geoghegan, P.; Clarke, J.; Silversides, J.; McGuigan, P.; Ward, K.; O’Neill, A.; Finn, S.; Wright, C.; Green, J.; Collins, É.; Knott, C.; Smith, J.; Boschert, C.; Slieker, K.; Ewalds, E.; Sanders, A.; Wittenberg, W.; Geurts, H.; Poojara, L.; Sara, T.; Nand, K.; Reeve, B.; Dechert, W.; Phillips, B.; Oritz-Ruiz de Gordoa, L.; Affleck, J.; Shaikh, A.; Murray, A.; Ramanan, M.; Frakking, T.; Pinnell, J.; Robinson, M.; Gledhill, L.; Wood, T.; Sanghavi, R.; Bhonagiri, D.; Ford, M.; Parikh, H.G.; Avard, B.; Nourse, M.; McDonald, B.; Edmunds, N.; Hoiting, O.; Peters, M.; Rengers, E.; Evers, M.; Prinssen, A.; Morgan, M.; Cole, J.; Hill, H.; Davies, M.; Williams, A.; Thomas, E.; Davies, R.; Wise, M.; Grimm, P.; Soukup, J.; Wetzold, R.; Löbel, M.; Starke, L.; Lellouche, F.; Lizotte, P.; Declerq, P.; Antoine, M.; Stephanie, G.; Jean-Pierre, E.; François, B.; Marion, B.; Philippe, R.; Pourcine, F.; Monchi, M.; Luis, D.; Mercier, R.; Sagnier, A.; Verrier, N.; Caplin, C.; Richecoeu, J.; Combaux, D.; Siami, S.; Aparicio, C.; Vautier, S.; Jeblaoui, A.; Lemaire-Brunel, D.; D’Aragon, F.; Carbonneau, E.; Leblond, J.; Plantefeve, G.; Leparco, C.; Contou, D.; Fartoukh, M.; Courtin, L.; Labbe, V.; Voiriot, G.; Salhi, S.; Chassé, M.; Carrier, F.; Boumahni, D.; Benettaib, F.; Ghamraoui, A.; Sement, A.; Gachet, A.; Hanisch, A.; Haffiane, A.; Boivin, A-H.; Barreau, A.; Guerineau, E.; Poupblanc, S.; Egreteau, P.; Lefevre, M.; Bocher, S.; Le Loup, G.; Le Guen, L.; Carn, V.; Bertel, M.; Antcliffe, D.; Templeton, M.; Rojo, R.; Coghlan, P.; Smee, J.; Barker, G.; Finn, A.; Kreb, G.; Hoff, U.; Hinrichs, C.; Nee, J.; Mackay, E.; Cort, J.; Whileman, A.; Spencer, T.; Spittle, N.; Beavis, S.; Padmakumar, A.; Dale, K.; Hawes, J.; Moakes, E.; Gascoyne, R.; Pritchard, K.; Stevenson, L.; Cooke, J.; Nemeth-Roszpopa, K.; Gauli, B.; Bastola, S.; Muller, G.; Nay, M-A.; Kamel, T.; Benzekri, D.; Jacquier, S.; Runge, I.; Mathonnet, A.; Barbier, F.; Bretagnol, A.; Carter, J.; Van Der Heyden, K.; Mehrtens, J.; Morris, A.; Morgan, S.; Burke, T.; Mercier, E.; Chartier, D.; Salmon, C.; Dequin, P-F.; Garot, D.; Bellemare, D.; Cloutier, È.; Daher, R.; Costerousse, O.; Boulanger, M-C.; Couillard-Chénard, É.; Lauzier, F.; Francoeur, C.; Francois, B.; Gay, A.; Anne-Laure, F.; Ramali, M.; Hc, O.; Ghosh, A.; Osagie, R.; Arachchige, M.; Hartley, M.; Cheung, W.; Wong, H.; Seigne, P.; Eustace, J.; O’Callaghan, A-M.; O’Brien, F.; Bamford, P.; Reid, A.; Cawley, K.; Faulkner, M.; Pickering, C.; Raj, A.; Tsinaslanidis, G.; Khade, R.; Agha, G.; Sekiwala, R.; Smith, T.; Brewer, C.; Gregory, J.; Limb, J.; Cowton, A.; O’Brien, J.; Postlethwaite, K.; Malakouti, S.; Music, E.; Ricketts, D.; King, A.; Clermont, G.; Bart, R.; Mayr, F.; Schoenling, A.; Andreae, M.; Shetty, V.; Brant, E.; Malley, B.; Donadee, C.; Sackrowitz, R.; Weissman, A.; Yealy, D.; Barton, D.; Talia, N.; Nikitas, N.; Wells, C.; Lankester, L.; McMillan, H.; van den Oever, H.; Kruisdijk-Gerritsen, A.; Haidar, G.; Bain, W.; Barbash, I.; Fitzpatrick, M.; Franz, C.; Kitsios, G.; Moghbeli, K.; Rosborough, B.; Shah, F.; Suber, T.; Pulletz, M.; Williams, P.; Birch, J.; Wiseman, S.; Horton, S.; Alegria, A.; Turki, S.; Elsefi, T.; Crisp, N.; Allen, L.; Truman, N.; Smith, M.; Chukkambotla, S.; Goddard, W.; Duberley, S.; Khan, M.; Kazi, A.; Simpson, J.; Duke, G.; Chan, P.; Carter, B.; Hunter, S.; Voigt, I.; Schueler, R.; Blank, E.; Hüning, V.; Steffen, M.; Goralski, P.; Litton, E.; Regli, A.; Pellicano, S.; Palermo, A.; Eroglu, E.; Bihari, S.; Laver, R.D.; Jin, X.; Brown, J.; McIntyre, J.; French, C.; Bates, S.; Towns, M.; Yang, Y.; McGain, F.; McCullagh, I.; Cairns, T.; Hanson, H.; Patel, B.; Clement, I.; Evetts, G.; Touma, O.; Holland, S.; Hodge, C.; Taylor, H.; Alderman, M.; Barnes, N.; Da Rocha, J.; Smith, C.; Brooks, N.; Weerasinghe, T.; Sinclair, J-A.; Abusamra, Y.; Doherty, R.; Cudlipp, J.; Singh, R.; Yu, H.; Daebis, A.; Ng, C.; Kendrick, S.; Saran, A.; Makky, A.; Greener, D.; Rowe-Leete, L.; Edwards, A.; Bland, Y.; Dolman, R.; Foster, T.; Laffey, J.; McNicholas, B.; Scully, M.; Casey, S.; Kernan, M.; Brennan, A.; Rangan, R.; Tully, R.; Corbett, S.; McCarthy, A.; Duffy, O.; Burke, D.; Linnett, V.; Sanderson, A.; Ritzema, J.; Wild, H.; Lucas, R.; Marriott, Y.; Andric, Z.; Cviljevic, S.; Br, R.; Zapalac, M.; Mirković, G.; Khare, D.; Pinder, M.; Gopinath, A.; Kannan, T.; Dean, S.; Vanmali, P.; Depuydt, P.; De Waele, J.; De Bus, L.; Fierens, J.; Bracke, S.; Vermassen, J.; Vermeiren, D.; Pugh, R.; Lean, R.; Qiu, X.; Scanlan, J.; Evans, A.; Davies, G.; Lewis, J.; Plesnikova, Y.; Khoud, A.; Coetzee, S.; Puxty, K.; Cathcart, S.; Rimmer, D.; Bagot, C.; Scott, K.; Martin, L.; Yusuff, H.; Isgro, G.; Brightling, C.; Bourne, M.; Craner, M.; Boyles, R.; Alexander, B.; Roberts, T.; Nelli, A.; Rosenstein-Sisson, R.; Speyer, R.; Pech, Y.; McCullough, J.; Tallott, M.; Vazquez-Grande, G.; Marten, N.; Liu, T.; Siddiqui, A.; Khanal, S.; Amatya, S.; Szakmany, T.; Cherian, S.; Williams, G.; James, C.; Waters, A.; Prout, R.; Stedman, R.; Davies, L.; Pegler, S.; Kyeremeh, L.; Moorhouse, L.; Arbane, G.; Marotti, M.; Bociek, A.; Campos, S.; van Nieuwkoop, K.; Ottens, T.; Visser, Y.; van den Berg, L.; van der Kraan-Donker, A.; Brett, S.; Arias, S.; Hall, R.; Paneru, H.; Koirala, S.; Paudel, P.; Wilson, M.; Vaara, S.; Pettilä, L.; Heinonen, J.; Pettilä, V.; Jain, S.; Gupta, A.; Holbrook, C.; Antoine, P.; Meziani, F.; Allam, H.; Cattelan, J.; Clere-Jehl, R.; Helms, J.; Kummerlen, C.; Merdji, H.; Monnier, A.; Rahmani, H.; Studer, A.; Schneider, F.; Castelain, V.; Morel, G.; L’Hotellier, S.; Ochin, E.; Vanjak, C.; Rouge, P.; Bendjemar, L.; Albert, M.; Serri, K.; Cavayas, A.; Duplaix, M.; Williams, V.; Catorze, N.J.T.A.S.; Pereira, T.N.A.L.; Ferreira, R.M.C.; Bastos, J.M.P.S.; Batista, T.M.O.; Badie, J.; Berdaguer, F.; Malfroy, S.; Mezher, C.; Bourgoin, C.; Moneger, G.; Bouvier, E.; Muñoz-Bermúdez, R.; Marin-Corral, J.; Degracia, A.; Gómez, F.; López, M.; Aceto, R.; Aghemo, A.; Badalamenti, S.; Brunetta, E.; Cecconi, M.; Ciccarelli, M.; Constantini, E.; Greco, M.; Folci, M.; Selmi, C.; Voza, A.; Henning, J.; Bonner, S.; Hugill, K.; Cirstea, E.; Wilkinson, D.; Jones, J.; Altomy, M.; Karlikowski, M.; Sutherland, H.; Wilhelmsen, E.; Woods, J.; North, J.; Pletz, M.; Hagel, S.; Ankert, J.; Kolanos, S.; Bloos, F.; Simons, K.; van Zuylen, T.; Bouman, A.; Kumar, N.; Panwar, R.; Poulter, A-L.; Sunkara, K.; Szigligeti, G.; Leszkoven, J.; Rochwerg, B.; Karachi, T.; Oczkowski, S.; Centofanti, J.; Millen, T.; Sundaran, D.; Hollos, L.; Williams, A.; Turns, M.; Walsh, J.; Al Qasim, E.; Alswaidan, L.; Hegazy, M.; Arishi, H.; Al Amri, A.; AlQahtani, S.; Naidu, B.; Tlayjeh, H.; Hussain, S.; Al Enezi, F.; Abdukahil, S.A.; Hopkins, P.; Smith, J.; Noble, H.; O’Reilly, K.; Mehta, R.; Wong, O.; Makanju, E.; Rao, D.; Sikondari, N.; Saha, S.; Corcoran, E.; Pappa, E.; Cockrell, M.; Donegan, C.; Balaie, M.; Nickoleit-Bitzenberger, D.; Schaaf, B.; Meermeier, W.; Prebeg, K.; Azzaui, H.; Hower, M.; Brieger, K-G.; Elender, C.; Sabelhaus, T.; Riepe, A.; Akamp, C.; Kremling, J.; Klein, D.; Landsiedel-Mechenbier, E.; Laha, S.; Verlander, M.; Williams, A.; Jha, A.; Megarbane, B.; Voicu, S.; Deye, N.; Malissin, I.; Sutterlin, L.; Mrad, A.; Lehalleur, A.; Naim, G.; Nguyen, P.; Ekhérian, J-M.; Boué, Y.; Sidéris, G.; Vodovar, D.; Guérin, E.; Grant, C.; Brain, M.; Mineall, S.; Paramasivam, E.; Wilby, E.; Ogg, B.; Howcroft, C.; Aspinwall, A.; Charlton, S.; Gould, R.; Mistry, D.; Awan, S.; Bedford, C.; Carr-Wilkinson, J.; Hall, A.; Cooke, J.; Gardiner-Hill, C.; Maloney, C.; Brunskill, N.; Watchorn, O.; Hardy, C.; Qureshi, H.; Flint, N.; Nicholson, S.; Southin, S.; Nicholson, A.; Ghattaoraya, A.; Harding, D.; O’Halloran, S.; Collins, A.; Smith, E.; Trues, E.; Borgatta, B.; Turner-Bone, I.; Reddy, A.; Wilding, L.; Wilson, C.; Surti, Z.; Aneman, A.; Miller, J.; White, H.; Estensen, K.; Morrison, L.; Sutton, J.; Cooper, M.; Warnapura, L.; Agno, R.; Sathianathan, P.; Shaw, D.; Ijaz, N.; Spong, A.; Sabaretnam, S.; Burns, D.; Lang, E.; Tate, M.; Fischer, R.; Biradar, V.; Soar, N.; Golden, D.; Davey, M.; Seaman, R.; Osborne, A.; Bannard-Smith, J.; Clark, R.; Birchall, K.; Henry, J.; Pomeroy, F.; Quayle, R.; Wylie, K.; Sukuraman, A.; John, M.; Sibin, S.; Leditschke, A.; Finnis, M.; Jongebloed, K.; Khwaja, K.; Campisi, J.; van Vonderen, M.; Pietersma, M.; Vrolijk, L.; Kampschreur, L.; van Gulik, L.; Makowski, A.; Misztal, B.; Haider, S.; Liao, A.; Squires, R.; Oborska, A.; Kayani, A.; Kalchko-Veyssal, S.; Prabakaran, R.; Hadebe, B.; KalchkoVeyssal, S.; Williams, T.; Song, R.; Morpeth, S.; Lai, V.; Habraken, H.; Stewart, R.; Mwaura, E.; Mew, L.; Wren, L.; Willams, F.; Sutherland, S-B.; Rebello, R.; Shehabi, Y.; Al-Bassam, W.; Hulley, A.; Kadam, U.; Sathianathan, K.; Innes, R.; Doble, P.; Graham, L.; Shovelton, C.; Dean, T.; Salahuddin, N.; Aryal, D.; Koirala, K.; Rai, N.; Luitel, S.; Seppelt, I.; Whitehead, C.; Lowrey, J.; Gresham, R.; Masters, K.; Hamlyn, V.; Hawkins, N.; Roynon-Reed, A.; Cutler, S.; Lewis, S.; Lazaro, J.; Newman, T.; Aravindan, L.; Asghar, A.; Bartholomew, J.; Bayne, M.; Beddows, S.; Birch, C.; Brend, M.; Byrne, R.; Campbell, D.; Campbell, H.; Chambers, E.; Clinton, A.; Collins, J.; Crawshaw, S.; Dawson, L.A.; Donaldson, K.; Drake, C.; Dyas, S.; Ellis, Y.; Gilmour, K.; Goodwin, J.; Halden, S.; Hall, A.S.; Hanson, J.; Harper, H.; Harrison, S.; Hayes, A.; Hodgson, H.; Hurford, S-A.; Jackson, S.; Levett, C.; Lock, S.; Lockett, T.; Logan, M.; Lomme, K.; Luo, J.; Marsh, E.; McKenna, S.; Mguni, N.; Monaghan, H.; Murphy, S.; Muzengi, N.; Naz, M.; O’Kell, E.; Oliver, A.; O’Reilly, J.; Pearson, K.; Porter, D.; Potter, A.; Rook, C.; Rounds, C.; Sheffield, J.; Shirley, K.; Siewersk, C.; Skinner, T.; Speight, H.; Sutu, M.; Unsworth, A.; Van’t Hoff, W.; Walker, S.; Williams, H.; Williams, P.; Williamson, D.; Williamson, J.D.; Duan, E.; Tsang, J.; Patterson, L.; Austin, P.; Chapman, S.; Cabrelli, L.; Fletcher, S.; Nortje, J.; Fottrell-Gould, D.; Randell, G.; Stammers, K.; Healey, G.; Pinto, M.; Borrill, Z.; Duncan, T.; Ustianowski, A.; Uriel, A.; Eltayeb, A.; Alfonso, J.; Hey, S.; Shaw, J.; Fox, C.; Lindergard, G.; Charles, B.; Blackledge, B.; Connolly, K.; Harris, J.; Cuesta, J.; Xavier, K.; Purohit, D.; Elhassan, M.; Haldeos, A.; Vincent, R.; Abdelrazik, M.; Jenkins, S.; Ganesan, A.; Kumar, R.; Carter, D.; Bakthavatsalam, D.; Frater, A.; Saleem, M.; Everitt, R.; Hacking, D.; Zaman, M.; Elmahi, E.; Jones, A.; Hall, K.; Phillips, M.; Terrill, L.; Mills, G.; Raithatha, A.; Bauchmuller, K.; Ryalls, K.; Harrington, K.; Bowler, H.; Sall, J.; Bourne, R.; Gross, J.; Massey, N.; Adebambo, O.; Long, M.; Tony, K.; Juffermans, N.; Koopmans, M.; Dujardin, R.; Alderink, B.; Rowland, M.; Hutton, P.; Bashyal, A.; Davidson, N.; Hird, C.; Chhablani, M.; Phalod, G.; Kirkby, A.; Archer, S.; Netherton, K.; Reschreiter, H.; Camsooksai, J.; Patch, S.; Jenkins, S.; Humphrey, C.; Flynn, G.; Harrington, C.; Kruger, P.; Walsham, J.; Meyer, J.; Harward, M.; Jones, C.; Sathe, S.; Roche, L.; Davies, E.; Skinner, D.; Gaylard, J.; Newman, J.; Pogson, D.; Rose, S.; Daly, Z.; Brimfield, L.; Nown, A.; Parekh, D.; Bergin, C.; Bates, M.; McGhee, C.; Lynch, D.; Bhandal, K.; Tsakiridou, K.; Bamford, A.; Cooper, L.; Whitehouse, T.; Veenith, T.; Forster, E.; O’Connell, M.; Sim, M.; Hay, S.; Henderson, S.; Nygren, M.; Valentine, E.; Katary, A.; Bell, G.; Wilcox, L.; Mataliotakis, M.; Smith, P.; Ali, M.; Isguzar, A.; Phull, M-K.; Zaidi, A.; Pogreban, T.; Rosaroso, L.; Harvey, D.; Lowe, B.; Meredith, M.; Ryan, L.; Schouten, J.; Pickkers, P.; Roovers, N.; Klop-Riehl, M.; van der Eng, H.; Sloots-Cuppen, S.; Preijers, L.; van Oosten, N.; Moine, P.; Heming, N.; Maxime, V.; Bossard, I.; Nicholier, T.; Clair, B.; Orlikowski, D.; Bounab, R.; Abdeladim, L.; Baker, S.; Duroux, M.; Ratcliffe, M.; Sy, E.; Mailman, J.; Lee, S.; Gupta, C.; Kassir, S.; López, R.; Rodríguez-Gómez, J.; Cárcel, S.; Carmona, R.; de la Fuente, C.; Rodriguez, M.; Jan Hassing, R.; Greven, F.; Huijbens, D.; Roebers, L.; Verheij, H.; Miles, H.; Attokaran, A.; Buehner, U.; Williams, E.; Chapman, M.; O’Connor, S.; Glasby, K.; Rivett, J.; Brown, N.; Kutsogiannis, D.; Thompson, P.; Rooney, K.; Rodden, N.; Thomson, N.; McGlynn, D.; Abel, L.; Gemmell, L.; Sundaram, R.; Hornsby, J.; Walden, A.; Keating, L.; Frise, M.; Rai, S.; Bartley, S.; Schuster-Bruce, M.; Pitts, S.; Miln, R.; Purandare, L.; Vamplew, L.; Patel, B.; Dempster, D.; Gummadi, M.; Dormand, N.; Wang, S.; Spivey, M.; Bean, S.; Burt, K.; Moore, L.; Hammonds, F.; Richards, C.; Campbell, L.; Smyth, K.; Day, C.; Zitter, L.; Benyon, S.; Singh, J.; Lynch, C.; Mikusek, J.; Deacon, B.; Turner, K.; Baker, E.; Hickey, J.; Champanerkar, S.; Aitken, L.; LewisProsser, L.; Ahmad, N.; Wiles, M.; Willson, J.; Grecu, I.; Martin, J.; Wrey Brown, C.; Arias, A-M.; Bevan, E.; Westlake, S.; Craven, T.; Hope, D.; Singleton, J.; Clark, S.; McCulloch, C.; Biddie, S.; Welters, I.; Hamilton, D.; Williams, K.; Waugh, V.; Shaw, D.; Mulla, S.; Waite, A.; Roman, J.; Martinez, M.; Johnston, B.; Puthucheary, Z.; Martin, T.; Santos, F.; Uddin, R.; Fernandez, M.; Seidu, F.; Somerville, A.; Pakats, M-L.; Begum, S.; Shahid, T.; Presneill, J.; Barge, D.; Byrne, K.; Janin, P.; Yarad, E.; Bass, F.; Hammond, N.; O’Connor, A.; Vuylsteke, A.; Chan, C.; Victor, S.; Waterson, S.; McNamara, R.; Boardman, M.; Gattas, D.; Buhr, H.; Coles, J.; Matsa, R.; Gellamucho, M.; Creagh-Brown, B.; Marriot, C.; Salberg, A.; Zouita, L.; Stone, S.; Michalak, N.; Donlon, S.; Mtuwa, S.; Mayangao, I.; Verula, J.; Burda, D.; Harris, C.; Jones, E.; Bradley, P.; Tarr, E.; Harden, L.; Piercy, C.; Nolan, J.; Kerslake, I.; Cook, T.; Simpson, T.; Dalton, J.; Demetriou, C.; Mitchard, S.; Ramos, L.; White, K.; Johnson, T.; Headdon, W.; Spencer, S.; White, A.; Howie, L.; Reay, M.; Jenkins, S.; Watts, A.; Traverse, E.; Jennings, S.; Anumakonda, V.; Tuckwell, C.; Harrow, K.; Matthews, J.; McGarry, K.; Moore, V.; Smith, L.; Summerfield, A.; Dark, P.; Harvey, A.; Doonan, R.; McMorrow, L.; Knowles, K.; Pendlebury, J.; Lee, S.; Perez, J.; Marsden, T.; Taylor, M.; Michael, A.; Collis, M.; Claxton, A.; Habeichi, W.; Horner, D.; Slaughter, M.; Thomas, V.; Proudfoot, N.; Keatley, C.; Donnison, P.; Casey, R.; Irving, B.; Matimba-Mupaya, W.; Reed, C.; Anthony, A.; Trim, F.; Cambalova, L.; Robertson, D.; Wilson, A.; Hulme, J.; Kannan, S.; Kinney, F.; Senya, H.; Hayes, A.; Ratnam, V.; Gill, M.; Kirk, J.; Shelton, S.; Schweikert, S.; Wibrow, B.; Anstey, M.; Rauniyar, R.; Khoso, N.; Asif, N.; Taqdees, H.; Frey, C.; Scano, R.; McKee, M.; Murphy, P.; Thomas, M.; Worner, R.; Faulkner, B.; Gendall, E.; Hayes, K.; Blakemore, H.; Borislavova, B.; Deshpande, K.; van Haren, F.; Konecny, P.; Inskip, D.; Tung, R.; Hayes, L.; Murphy, L.; Neill, A.; Reidy, B.; O’Dwyer, M.; Ryan, D.; Ainscough, K.; Hamilton-Davies, C.; Chan, C.; Mfuko, C.; Abbass, H.; Mandadapu, V.; Leaver, S.; Patel, K.; Farnell-Ward, S.; Saluzzio, R.; Rawlins, S.; Sicat, C.; De Keulenaer, B.; Ferrier, J.; Fysh, E.; Davda, A.; Mevavala, B.; Cook, D.; Clarke, F.; Banach, D.; Fernández de Pinedo Artaraz, Z.; Cabreros, L.; Latham, V.; Kruisselbrink, R.; Brochard, L.; Burns, K.; Sandhu, G.; Khalid, I.; White, I.; Croft, M.; Holland, N.; Pereira, R.; Nair, P.; Buscher, H.; Reynolds, C.; Newman, S.; Santamaria, J.; Barbazza, L.; Homes, J.; Smith, R.; Zaki, A.; Johnson, D.; Garrard, H.; Juhaz, V.; Brown, L.; Pemberton, A.; Roy, A.; Rostron, A.; Woods, L.; Cornell, S.; Fowler, R.; Adhikari, N.; Kamra, M.; Marinoff, N.; Garrett, P.; Murray, L.; Brailsford, J.; Fennessy, G.; Mulder, J.; Morgan, R.; Pillai, S.; Harford, R.; Ivatt, H.; Evans, D.; Richards, S.; Roberts, E.; Bowen, J.; Ainsworth, J.; Kuitunen, A.; Karlsson, S.; Vahtera, A.; Kiiski, H.; Ristimäki, S.; Albrett, J.; Jackson, C.; Kirkham, S.; Tamme, K.; Reinhard, V.; Ellervee, A.; Põldots, L.; Rennit, P.; Svitškar, N.; Browne, T.; Grimwade, K.; Goodson, J.; Keet, O.; Callender, O.; Udy, A.; McCracken, P.; Young, M.; Board, J.; Martin, E.; Kasipandian, V.; Patel, A.; Allibone, S.; Mary-Genetu, R.; English, S.; Watpool, I.; Porteous, R.; Miezitis, S.; McIntyre, L.; Brady, K.; Vale, C.; Shekar, K.; Lavana, J.; Parmar, D.; Peake, S.; Kurenda, C.; Hormis, A.; Walker, R.; Collier, D.; Kimpton, S.; Oakley, S.; Bhagani, S.; De Neef, M.; Garcia, S.; Maharajh, A.; Nandani, A.; Dobson, J.; Fernando, G.; Eastgate, C.; Gomez, K.; Abdi, Z.; Tatham, K.; Jhanji, S.; Black, E.; Dela Rosa, A.; Howle, R.; Baikady, R.; Tully, R.; Drummond, A.; Dearden, J.; Philbin, J.; Munt, S.; Gopal, S.; Pooni, J-S.; Ganguly, S.; Smallwood, A.; Metherell, S.; Naeem, A.; Fagan, L.; Ryan, E.; Mariappa, V.; Smith, J.; Foulds, A.; Revill, A.; Bhattarai, B.; de Jonge, E.; Wigbers, J.; del Prado, M.; Cremer, O.; Mulier, J.; Peters, A.; Romberg, B.; Schutgens, R.; Troeman, D.; Van Opdorp, M.; Besten, H.; Brakké, K.; Barber, R.; Hilldrith, A.; Kluge, S.; Nierhaus, A.; Jarczak, D.; Roedl, K.; Kochanek, M.; Rueß-Paterno, G.; Mc-Kenzie, J.; Eichenauer, D.; Shimabukuro-Vornhagen, A.; Wilcox, E.; del Sorbo, L.; Abdelhady, H.; Romagnuolo, T.; Simpson, S.; Maiden, M.; Horton, M.; Trickey, J.; Krajinovic, V.; Kutleša, M.; Kotarski, V.; Brohi, F.; Jagannathan, V.; Clark, M.; Purvis, S.; Wetherill, B.; Brajković, A.; Babel, J.; Sever, H.; Dragija, L.; Kušan, I.; Dushianthan, A.; Cusack, R.; de Courcy-Golder, K.; Salmon, K.; Burnish, R.; Smith, S.; Jackson, S.; Ruiz, W.; Duke, Z.; Johns, M.; Male, M.; Gladas, K.; Virdee, S.; Swabe, J.; Tomlinson, H.; Rohde, G.; Grünewaldt, A.; Bojunga, J.; Petros, S.; Kunz, K.; Schütze, B.; Weismann, D.; Frey, A.; Drayss, M.; Goebeler, M.E.; Flor, T.; Fragner, G.; Wahl, N.; Totzke, J.; Sayehli, C.; Hakak, S.; Altaf, W.; O’Sullivan, M.; Murphy, A.; Walsh, L.; Rega La Valle, A.; Bewley, J.; Sweet, K.; Grimmer, L.; Johnson, R.; Wyatt, R.; Morgan, K.; Varghese, S.; Willis, J.; Stratton, E.; Kyle, L.; Putensen, D.; Drury, K.; Skorko, A.; Bremmer, P.; Ward, G.; Bassford, C.; Sligl, W.; Baig, N.; Rewa, O.; Bagshaw, S.; Basile, K.; Stavor, D.; Burbee, D.; McNamara, A.; Wunderley, R.; Bensen, N.; Richardson, A.; Adams, P.; Vita, T.; Buhay, M.; Scholl, D.; Gilliam, M.; Winters, J.; Doherty, K.; Berryman, E.; Ghaffari, M.; Marroquin, O.; Quinn, K.; Garrard, W.; Kalchthaler, K.; Beard, G.; Skrtich, A.; Bagavathy, K.; Drapola, D.; Bryan-Morris, K.; Arnold, J.; Reynolds, B.; Hussain, M.; Dunsavage, J.; Saiyed, S.; Hernandez, E.; Goldman, J.; Brown, C.; Comp, S.; Raczek, J.; Morris, J.; Vargas, J., Jr; Weiss, D.; Hensley, J.; Kochert, E.; Wnuk, C.; Nemeth, C.; Mowery, B.; Hutchinson, C.; Winters, L.; McAdams, D.; Walker, G.; Minnier, T.; Wisniewski, M.; Mayak, K.; McCreary, E.; Martin, E.; Bariola, R.; Viehman, A.; Daley, J.; Lopus, A.; Schmidhofer, M.; Ambrosino, R.; Keen, S.; Toffalo, S.; Stambaugh, M.; Trimmer, K.; Perri, R.; Casali, S.; Medva, R.; Massar, B.; Beyerl, A.; Burkey, J.; Keeler, S.; Lowery, M.; Oncea, L.; Daugherty, J.; Sevilla, C.; Woelke, A.; Dice, J.; Weber, L.; Roth, J.; Ferringer, C.; Beer, D.; Fesz, J.; Carpio, L.; Colin, G.; Zinzoni, V.; Maquigneau, N.; Henri-Lagarrigue, M.; Pouplet, C.; Reill, L.; Distler, M.; Maselli, A.; Martynoga, R.; Trask, K.; Butler, A.; Attwood, B.; Parsons, P.; Campbell, B.; Smith, A.; Page, V.; Zhao, X.; Oza, D.; Abrahamson, G.; Sheath, B.; Ellis, C.; Young, P.; Young, C.; Lesona, E.; Navarra, L.; Cruz, R.; Delaney, K.; Cruz, R.; Aguilar-Dano, A.; Gojanovic, M.; Rhodes, J.; Anderson, T.; Morris, S.; Nayyar, V.; Bowen, D.; Kong, J.; Joy, J.; Fuchs, R.; Lambert, B.; Tai, C.; Thomas, A.; Keen, A.; Tierney, C.; Omer, N.; Bacon, G.; Tridente, A.; Shuker, K.; Anders, J.; Greer, S.; Scott, P.; Millington, A.; Buchanan, P.; Kirk, J.; Binnie, A.; Powell, E.; McMillan, A.; Luk, T.; Aref, N.; Denmade, C.; Sadera, G.; Jacob, R.; Jones, C.; Hughes, D.; Sterba, M.; Geng, W.; Digby, S.; Southern, D.; Reddy, H.; Hulse, S.; Campbell, A.; Garton, M.; Watkins, C.; Smuts, S.; Quinn, A.; Simpson, B.; McMillan, C.; Finch, C.; Hill, C.; Cooper, J.; Budd, J.; Small, C.; O’Leary, R.; Birch, J.; Collins, E.; Holland, A.; Alexander, P.; Felton, T.; Ferguson, S.; Sellers, K.; Ward, L.; Yates, D.; Birkinshaw, I.; Kell, K.; Scott, Z.; Pearson, H.; Hashmi, M.; Ali, M.; Hassan, N.; Panjwani, A.; Umrani, Z.; Shaikh, M.; Siddiqui, A.; Ain, Q.; Kanwal, D.; van Bree, S.; Bouw-Ruiter, M.; Osinga, M.; van Zanten, A.; McEldrew, R.; Rashan, S.; Singh, V.; Azergui, N.; Bari, S.; Beltran, M.; Brugman, C.; Groeneveld, E.; Jafarzadeh, M.; Keijzer-Timmers, N.; Kester, E.; Koelink, M.; Kwakkenbos-Craanen, M.; Okundaye, C.; Parker, L.; Peters, S.; Post, S.; Rietveld, I.; Scheepstra-Beukers, I.; Schreuder, G.; Smit, A.; Brillinger, N.; Markgraf, R.; Eichinger, F.; Doran, P.; Anjum, A.; Best-Lane, J.; Barton, F.; Miller, L.; Peters, S.; Richards-Belle, A.; Saull, M.; Sprinckmoller, S.; Wiley, D.; Darnell, R.; Au, C.; Lindstrum, K.; Cheng, A.; Forbes, A.; Heritier, S.; Trapani, T.; Cuthbertson, B.; Manoharan, V.; Dondrop, A.; Jayakumar, D.; Tolppa, T.; Ehrmann, S.; Hullegie, S.; Povoa, P.; Beasley, R.; Daneman, N.; Fowler, R.; McGloughlin, S.; Paterson, D.; Venkatesh, B.; de Jong, M.; Uyeki, T.; Baillie, K.; Hashmi, M.; Netea, M.; Orr, K.; Patanwala, A.; Tong, S.; Cooper, N.; Galea, J.; Leavis, H.; Ogungbenro, K.; Patawala, A.; Rademaker, E.; Tong, S.; Youngstein, T.; Carrier, M.; Fergusson, D.; Hunt, B.; Kumar, A.; Laffan, M.; Lother, S.; Middeldorp, S.; Stanworth, S.; de Man, A.; Masse, M-H.; Abraham, J.; Arnold, D.; Begin, P.; Charlewood, R.; Chasse, M.; Cooper, J.; Coyne, M.; Daly, J.; Gosbell, I.; Harvala-Simmonds, H.; MacLennan, S.; McDyer, J.; Menon, D.; Pridee, N.; Roberts, D.; Thomas, H.; Tinmouth, A.; Triulzi, D.; Walsh, T.; Wood, E.; Calfee, C.; O’Kane, C.; Shyamsundar, M.; Sinha, P.; Thompson, T.; Young, I.; Burrell, A.; Ferguson, N.; Hodgson, C.; Orford, N.; Phua, J.; Baron, R.; Epelman, S.; Frankfurter, C.; Gommans, F.; Kim, E.; Leaf, D.; Vaduganathan, M.; van Kimmenade, R.; Sanil, A.; van Beurden, M.; Effelaar, E.; Schotsman, J.; Boyd, C.; Harland, C.; Shearer, A.; Wren, J.; Clermont, G.; Ricketts, D.; Attanayaka, U.; Darshana, S.; Ishani, P.; Udayanga, I.; Higgins, A.M.; Berry, L.R.; Lorenzi, E.; Murthy, S.; McQuilten, Z.; Mouncey, P.R.; Al-Beidh, F.; Annane, D.; Arabi, Y.M.; Beane, A.; van Bentum-Puijk, W.; Bhimani, Z.; Bonten, M.J.M.; Bradbury, C.A.; Brunkhorst, F.M.; Burrell, A.; Buzgau, A.; Buxton, M.; Charles, W.N.; Cove, M.; Detry, M.A.; Estcourt, L.J.; Fagbodun, E.O.; Fitzgerald, M.; Girard, T.D.; Goligher, E.C.; Goossens, H.; Haniffa, R.; Hills, T.; Horvat, C.M.; Huang, D.T.; Ichihara, N.; Lamontagne, F.; Marshall, J.C.; McAuley, D.F.; McGlothlin, A.; McGuinness, S.P.; McVerry, B.J.; Neal, M.D.; Nichol, A.D.; Parke, R.L.; Parker, J.C.; Parry-Billings, K.; Peters, S.E.C.; Reyes, L.F.; Rowan, K.M.; Saito, H.; Santos, M.S.; Saunders, C.T.; Serpa-Neto, A.; Seymour, C.W.; Shankar-Hari, M.; Stronach, L.M.; Turgeon, A.F.; Turner, A.M.; van de Veerdonk, F.L.; Zarychanski, R.; Green, C.; Lewis, R.J.; Angus, D.C.; McArthur, C.J.; Berry, S.; Derde, L.P.G.; Gordon, A.C.; Webb, S.A.; Lawler, P.R. Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial. JAMA, 2023, 329(1), 39-51.
[http://dx.doi.org/10.1001/jama.2022.23257] [PMID: 36525245]
[96]
Biran, N.; Ip, A.; Ahn, J.; Go, R.C.; Wang, S.; Mathura, S.; Sinclaire, B.A.; Bednarz, U.; Marafelias, M.; Hansen, E.; Siegel, D.S.; Goy, A.H.; Pecora, A.L.; Sawczuk, I.S.; Koniaris, L.S.; Simwenyi, M.; Varga, D.W.; Tank, L.K.; Stein, A.A.; Allusson, V.; Lin, G.S.; Oser, W.F.; Tuma, R.A.; Reichman, J.; Brusco, L., Jr; Carpenter, K.L.; Costanzo, E.J.; Vivona, V.; Goldberg, S.L. Tocilizumab among patients with COVID-19 in the intensive care unit: A multicentre observational study. Lancet Rheumatol., 2020, 2(10), e603-e612.
[http://dx.doi.org/10.1016/S2665-9913(20)30277-0] [PMID: 32838323]
[97]
Zangrillo, A.; Beretta, L.; Scandroglio, A.M.; Monti, G.; Fominskiy, E.; Colombo, S.; Morselli, F.; Belletti, A.; Silvani, P.; Crivellari, M.; Monaco, F.; Azzolini, M.L.; Reineke, R.; Nardelli, P.; Sartorelli, M.; Votta, C.D.; Ruggeri, A.; Ciceri, F.; De Cobelli, F.; Tresoldi, M.; Dagna, L.; Rovere-Querini, P.; Neto, A.S.; Bellomo, R.; Landoni, G. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit. Care Resusc., 2020, 22(3), 200-211.
[http://dx.doi.org/10.1016/S1441-2772(23)00387-3] [PMID: 32900326]
[98]
Investigators, T.R.-C. and L.P.G. Derde, Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial. medRxiv, 2021, 2021.06.18.21259133.
[99]
Salama, C.; Han, J.; Yau, L.; Reiss, W.G.; Kramer, B.; Neidhart, J.D.; Criner, G.J.; Kaplan-Lewis, E.; Baden, R.; Pandit, L.; Cameron, M.L.; Garcia-Diaz, J.; Chávez, V.; Mekebeb-Reuter, M.; Lima de Menezes, F.; Shah, R.; González-Lara, M.F.; Assman, B.; Freedman, J.; Mohan, S.V. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med., 2021, 384(1), 20-30.
[http://dx.doi.org/10.1056/NEJMoa2030340] [PMID: 33332779]
[100]
Furlow, B. COVACTA trial raises questions about tocilizumab’s benefit in COVID-19. Lancet Rheumatol., 2020, 2(10), e592.
[http://dx.doi.org/10.1016/S2665-9913(20)30313-1] [PMID: 32929415]
[101]
Rosas, I.O.; Bräu, N.; Waters, M.; Go, R.C.; Hunter, B.D.; Bhagani, S.; Skiest, D.; Aziz, M.S.; Cooper, N.; Douglas, I.S.; Savic, S.; Youngstein, T.; Del Sorbo, L.; Gracian, A.C.; De La Zerda, D.J.; Ustianowski, A.; Bao, M.; Dimonaco, S.; Graham, E.; Matharu, B.; Spotswood, H.; Tsai, L.; Malhotra, A. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N. Engl. J. Med., 2021, 384(16), 1503-1516.
[http://dx.doi.org/10.1056/NEJMoa2028700] [PMID: 33631066]
[102]
Veiga, V.C.; Prats, J.A.G.G.; Farias, D.L.C.; Rosa, R.G.; Dourado, L.K.; Zampieri, F.G.; Machado, F.R.; Lopes, R.D.; Berwanger, O.; Azevedo, L.C.P.; Avezum, Á.; Lisboa, T.C.; Rojas, S.S.O.; Coelho, J.C.; Leite, R.T.; Carvalho, J.C.; Andrade, L.E.C.; Sandes, A.F.; Pintão, M.C.T.; Castro, C.G., Jr; Santos, S.V.; de Almeida, T.M.L.; Costa, A.N.; Gebara, O.C.E.; de Freitas, F.G.R.; Pacheco, E.S.; Machado, D.J.B.; Martin, J.; Conceição, F.G.; Siqueira, S.R.R.; Damiani, L.P.; Ishihara, L.M.; Schneider, D.; de Souza, D.; Cavalcanti, A.B.; Scheinberg, P. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: Randomised controlled trial. BMJ, 2021, 372, n84.
[http://dx.doi.org/10.1136/bmj.n84] [PMID: 33472855]
[103]
National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2022.Available from: https://www.covid19treatmentguidelines.nih.gov/,
[104]
Rosas, I.O.; Diaz, G.; Gottlieb, R.L.; Lobo, S.M.; Robinson, P.; Hunter, B.D.; Cavalcante, A.W.; Overcash, J.S.; Hanania, N.A.; Skarbnik, A.; Garcia-Diaz, J.; Gordeev, I.; Carratalà, J.; Gordon, O.; Graham, E.; Lewin-Koh, N.; Tsai, L.; Tuckwell, K.; Cao, H.; Brainard, D.; Olsson, J.K. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: A randomized clinical trial. Intensive Care Med., 2021, 47(11), 1258-1270.
[http://dx.doi.org/10.1007/s00134-021-06507-x] [PMID: 34609549]
[105]
Lescure, F.X.; Honda, H.; Fowler, R.A.; Lazar, J.S.; Shi, G.; Wung, P.; Patel, N.; Hagino, O.; Bazzalo, I.J.; Casas, M.M.; Nuñez, S.A.; Pere, Y.; Ibarrola, C.M.; Solis Aramayo, M.A.; Cuesta, M.C.; Duarte, A.E.; Gutierrez Fernandez, P.M.; Iannantuono, M.A.; Miyazaki, E.A.; Silvio, J.P.; Scublinsky, D.G.; Bales, A.; Catarino, D.; Fiss, E.; Mohrbacher, S.; Sato, V.; Baylao, A.; Cavalcante, A.; Correa, F.; de Andrade, C.A.; Furtado, J.; Ribeiro Filho, N.; Telles, V.; Trevelin, L.T.; Vipich, R.; Boldo, R.; Borges, P.; Lobo, S.; Luckemeyer, G.; Machado, L.; Alves, M.B.; Iglessias, A.C.; Lago, M.M.; Santos, D.W.; Chapdelaine, H.; Falcone, E.L.; Jamal, R.; Luong, M-L.; Durand, M.; Doucet, S.; Carrier, F-M.; Coburn, B.A.; Del Sorbo, L.; Walmsley, S.L.; Belga, S.; Chen, L.Y.; Mah, A.D.; Steiner, T.; Wright, A.J.; Hajek, J.; Adhikari, N.; Fowler, R.A.; Daneman, N.; Khwaja, K.A.; Shahin, J.; Gonzalez, C.; Silva, R.; Lindh, M.; Maluenda, G.; Fernandez, P.; Oyonarte, M.; Lasso, M.; Boyer, A.; Bronnimann, D.; Bui, H-N.; Cazanave, C.; Chaussade, H.; Desclaux, A.; Ducours, M.; Duvignaud, A.; Malvy, D.; Martin, L.; Neau, D.; Nguyen, D.; Pistone, T.; Soubrane-Wirth, G.; Leitao, J.; Allavena, C.; Biron, C.; Bouchez, S.; Gaborit, B.; Gregoire, A.; Le Turnier, P.; Lecompte, A-S.; Lecomte, R.; Lefebvre, M.; Raffi, F.; Boutoille, D.; Morineau, P.H.; Guéry, R.; Chatelus, E.; Dumoussaud, N.; Felten, R.; Luca, F.; Goichot, B.; Schneider, F.; Taquet, M-C.; Groh, M.; Roumier, M.; Neuville, M.; Bachelard, A.; Isernia, V.; Lescure, F-X.; Phung, B-C.; Rachline, A.; Sautereau, A.; Vallois, D.; Bleher, Y.; Boucher, D.; Coudon, C.; Esnault, J.; Guimard, T.; Leautez-Nainville, S.; Merrien, D.; Morrier, M.; Motte-Vincent, P.; Gabeff, R.; Leclerc, H.; Cozic, C.; Decours, R.; Février, R.; Colin, G.; Abgrall, S.; Vignes, D.; Sterpu, R.; Kuellmar, M.; Meersch-Dini, M.; Weiss, R.; Zarbock, A.; Antony, C.; Berger, M.; Brenner, T.; Taube, C.; Herbstreit, F.; Dolff, S.; Konik, M.; Schmidt, K.; Zettler, M.; Witzke, O.; Boell, B.; Garcia Borrega, J.; Koehler, P.; Zander, T.; Dusse, F.; Al-Sawaf, O.; Köhler, P.; Eichenauer, D.; Kochanek, M.; Shimabukuro-Vornhagen, A.; Mellinghoff, S.; Claßen, A.; Heger, J-M.; Meyer-Schwickerath, C.; Liedgens, P.; Heindel, K.; Belkin, A.; Biber, A.; Gilboa, M.; Levy, I.; Litachevsky, V.; Rahav, G.; Finesod Wiedner, A.; Zilberman-Daniels, T.; Oster, Y.; Strahilevitz, J.; Sviri, S.; Baldissera, E.M.; Campochiaro, C.; Cavalli, G.; Dagna, L.; De Luca, G.; Della Torre, E.; Tomelleri, A.; Bernasconi De Luca, D.; Capetti, A.F.; Coen, M.; Cossu, M.V.; Galli, M.; Giacomelli, A.; Gubertini, G.A.; Rusconi, S.; Burastero, G.J.; Digaetano, M.; Guaraldi, G.; Meschiari, M.; Mussini, C.; Puzzolante, C.; Volpi, S.; Aiello, M.; Ariani, A.; Chetta, A.A.; Frizzelli, A.; Ticinesi, A.; Tuttolomondo, D.; Aliberti, S.; Blasi, F.B.; Di Pasquale, M.F.; Misuraca, S.; Pilocane, T.; Simonetta, E.; Aghelmo, A.M.; Angelini, C.; Brunetta, E.; Canonica, G.W.; Ciccarelli, M.; Dal Farra, S.; De Santis, M.; Ferri, S.; Folci, M.; Guidelli, G.M.; Heffler, E.M.; Loiacono, F.; Malipiero, G.; Paoletti, G.; Pedale, R.; Puggioni, F.A.; Racca, F.; Zumbo, A.; Satou, M.; Honda, H.; Lisun, T.; Protsenko, D.; Rubtsov, N.; Beloglazova, I.; Fomina, D.; Lysenko, M.; Serdotetskova, S.; Firstov, V.; Gordeev, I.; Kokorin, I.; Komissarova, K.; Lapochkina, N.; Luchinkina, E.; Malimon, V.; Mamedguseyinova, S.; Polubatonova, K.; Suvorova, N.; Arribas, J.; Borobia, P.A.M.; de la Calle, P.F.; Figueira, J.C.; Motejano, S.R.; Mora-Rillo, M.; Prados, S.C.; Queiruga, P.J.; Fernandez, A.F.; Guerro, B.M.; Bendala, E.A.; Caballero, M.A.; Garcia, L.M.E.; García-Martínez, R.; Collado, A.M.; Munoz, G.P.; Torres do, R.A.; Villalba, G.M.V.; Burrillo, A.; Valerio, M.M.; Gijon, V.P.; Infante, H.S.; Velilla, E.; Machado, M.; Olmedo, M.; Pinilla, B.; Almirante, G.B.; Cañas, R.M.E.; Contreras, M.S.; Cortés, H.A.; Falcó, F.V.; Ferrer, R.R.; Nuvials, C.X.; Ribera, P.E.; Suanzes, D.P.; Rebollo, C.P.; Garcia, A.F.; Soriano, A.; Oliver, C.A.; González, C.A.; Cardozo, C.; De la Mora, C.L.; Pena, L.R.; Chamorro, S.; Crespillo-Andujar, C.; Escudero, S.R.; Fortún-Abete, J.; Monge-Maillo, B.; Moreno, Z.A.; Norman, F.; Sanchez, C.M.; Serrano, V.S.; Vizcarra, P. Sarilumab in patients admitted to hospital with severe or critical COVID-19: A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir. Med., 2021, 9(5), 522-532.
[http://dx.doi.org/10.1016/S2213-2600(21)00099-0] [PMID: 33676590]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy